nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—ACHE—Alzheimer's disease	0.187	0.523	CbGaD
Procainamide—ACHE—Rivastigmine—Alzheimer's disease	0.116	0.253	CbGbCtD
Procainamide—BCHE—Alzheimer's disease	0.11	0.308	CbGaD
Procainamide—ACHE—Donepezil—Alzheimer's disease	0.0926	0.202	CbGbCtD
Procainamide—BCHE—Rivastigmine—Alzheimer's disease	0.0698	0.152	CbGbCtD
Procainamide—CYP2D6—Alzheimer's disease	0.0605	0.169	CbGaD
Procainamide—ACHE—Galantamine—Alzheimer's disease	0.0597	0.13	CbGbCtD
Procainamide—SLC22A2—Memantine—Alzheimer's disease	0.0461	0.101	CbGbCtD
Procainamide—BCHE—Galantamine—Alzheimer's disease	0.0359	0.0784	CbGbCtD
Procainamide—CYP2D6—Rivastigmine—Alzheimer's disease	0.0167	0.0364	CbGbCtD
Procainamide—CYP2D6—Donepezil—Alzheimer's disease	0.0133	0.0291	CbGbCtD
Procainamide—CYP2D6—Galantamine—Alzheimer's disease	0.00859	0.0187	CbGbCtD
Procainamide—SCN8A—cerebellar cortex—Alzheimer's disease	0.00694	0.168	CbGeAlD
Procainamide—Cardiac fibrillation—Rivastigmine—Alzheimer's disease	0.00283	0.0382	CcSEcCtD
Procainamide—Electrocardiogram change—Memantine—Alzheimer's disease	0.00264	0.0357	CcSEcCtD
Procainamide—Supraventricular tachycardia—Galantamine—Alzheimer's disease	0.00164	0.0221	CcSEcCtD
Procainamide—Supraventricular tachycardia—Donepezil—Alzheimer's disease	0.00127	0.0171	CcSEcCtD
Procainamide—Supraventricular tachycardia—Memantine—Alzheimer's disease	0.00115	0.0156	CcSEcCtD
Procainamide—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00113	0.0153	CcSEcCtD
Procainamide—Supraventricular tachycardia—Rivastigmine—Alzheimer's disease	0.00113	0.0152	CcSEcCtD
Procainamide—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00107	0.0145	CcSEcCtD
Procainamide—SCN8A—forebrain—Alzheimer's disease	0.00105	0.0256	CbGeAlD
Procainamide—DNMT1—embryo—Alzheimer's disease	0.00103	0.0249	CbGeAlD
Procainamide—SCN8A—telencephalon—Alzheimer's disease	0.000969	0.0235	CbGeAlD
Procainamide—Pleural effusion—Rivastigmine—Alzheimer's disease	0.000964	0.013	CcSEcCtD
Procainamide—DNMT1—forebrain—Alzheimer's disease	0.000909	0.022	CbGeAlD
Procainamide—DNMT1—telencephalon—Alzheimer's disease	0.000835	0.0203	CbGeAlD
Procainamide—Atrial fibrillation—Galantamine—Alzheimer's disease	0.000821	0.0111	CcSEcCtD
Procainamide—Renal impairment—Galantamine—Alzheimer's disease	0.000818	0.0111	CcSEcCtD
Procainamide—Oliguria—Rivastigmine—Alzheimer's disease	0.000801	0.0108	CcSEcCtD
Procainamide—Arthritis—Galantamine—Alzheimer's disease	0.000801	0.0108	CcSEcCtD
Procainamide—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.000798	0.0108	CcSEcCtD
Procainamide—Cardiac failure—Galantamine—Alzheimer's disease	0.000797	0.0108	CcSEcCtD
Procainamide—SCN1A—forebrain—Alzheimer's disease	0.000797	0.0193	CbGeAlD
Procainamide—Lethargy—Galantamine—Alzheimer's disease	0.000794	0.0107	CcSEcCtD
Procainamide—Vasculitis—Rivastigmine—Alzheimer's disease	0.000756	0.0102	CcSEcCtD
Procainamide—SCN11A—nervous system—Alzheimer's disease	0.000755	0.0183	CbGeAlD
Procainamide—SCN1A—telencephalon—Alzheimer's disease	0.000733	0.0178	CbGeAlD
Procainamide—SCN2A—forebrain—Alzheimer's disease	0.000731	0.0177	CbGeAlD
Procainamide—SCN11A—central nervous system—Alzheimer's disease	0.000727	0.0176	CbGeAlD
Procainamide—Abdominal pain upper—Galantamine—Alzheimer's disease	0.000711	0.00961	CcSEcCtD
Procainamide—SCN10A—forebrain—Alzheimer's disease	0.000705	0.0171	CbGeAlD
Procainamide—ACHE—telencephalon—Alzheimer's disease	0.000679	0.0165	CbGeAlD
Procainamide—SCN2A—telencephalon—Alzheimer's disease	0.000673	0.0163	CbGeAlD
Procainamide—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.000671	0.00907	CcSEcCtD
Procainamide—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.000668	0.00903	CcSEcCtD
Procainamide—SCN10A—telencephalon—Alzheimer's disease	0.000648	0.0157	CbGeAlD
Procainamide—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000645	0.00872	CcSEcCtD
Procainamide—SCN3A—forebrain—Alzheimer's disease	0.000643	0.0156	CbGeAlD
Procainamide—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000636	0.0086	CcSEcCtD
Procainamide—Arthritis—Donepezil—Alzheimer's disease	0.000621	0.00839	CcSEcCtD
Procainamide—Cardiac failure—Donepezil—Alzheimer's disease	0.000618	0.00836	CcSEcCtD
Procainamide—Hepatic failure—Memantine—Alzheimer's disease	0.000609	0.00824	CcSEcCtD
Procainamide—Depression—Galantamine—Alzheimer's disease	0.000598	0.00808	CcSEcCtD
Procainamide—SCN3A—telencephalon—Alzheimer's disease	0.000591	0.0143	CbGeAlD
Procainamide—Renal failure—Galantamine—Alzheimer's disease	0.00059	0.00797	CcSEcCtD
Procainamide—Psychotic disorder—Donepezil—Alzheimer's disease	0.000589	0.00796	CcSEcCtD
Procainamide—SLC22A3—embryo—Alzheimer's disease	0.000579	0.014	CbGeAlD
Procainamide—Atrial fibrillation—Memantine—Alzheimer's disease	0.000578	0.00781	CcSEcCtD
Procainamide—SCN11A—brain—Alzheimer's disease	0.000577	0.014	CbGeAlD
Procainamide—Renal impairment—Memantine—Alzheimer's disease	0.000575	0.00778	CcSEcCtD
Procainamide—SCN8A—nervous system—Alzheimer's disease	0.000572	0.0139	CbGeAlD
Procainamide—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000565	0.00764	CcSEcCtD
Procainamide—Arthritis—Memantine—Alzheimer's disease	0.000563	0.00762	CcSEcCtD
Procainamide—Renal impairment—Rivastigmine—Alzheimer's disease	0.000563	0.00761	CcSEcCtD
Procainamide—Cardiac failure—Memantine—Alzheimer's disease	0.000561	0.00759	CcSEcCtD
Procainamide—Lethargy—Memantine—Alzheimer's disease	0.000559	0.00756	CcSEcCtD
Procainamide—Arthritis—Rivastigmine—Alzheimer's disease	0.000551	0.00745	CcSEcCtD
Procainamide—SCN8A—central nervous system—Alzheimer's disease	0.000551	0.0134	CbGeAlD
Procainamide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000551	0.00745	CcSEcCtD
Procainamide—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000549	0.00742	CcSEcCtD
Procainamide—Bradycardia—Galantamine—Alzheimer's disease	0.000548	0.00741	CcSEcCtD
Procainamide—CHRM2—forebrain—Alzheimer's disease	0.000546	0.0132	CbGeAlD
Procainamide—SCN8A—cerebellum—Alzheimer's disease	0.000538	0.0131	CbGeAlD
Procainamide—SLC22A1—forebrain—Alzheimer's disease	0.000536	0.013	CbGeAlD
Procainamide—Hallucination—Galantamine—Alzheimer's disease	0.000536	0.00724	CcSEcCtD
Procainamide—Psychotic disorder—Memantine—Alzheimer's disease	0.000535	0.00723	CcSEcCtD
Procainamide—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000523	0.00707	CcSEcCtD
Procainamide—Cardiac arrest—Memantine—Alzheimer's disease	0.000521	0.00704	CcSEcCtD
Procainamide—Eosinophilia—Donepezil—Alzheimer's disease	0.000516	0.00698	CcSEcCtD
Procainamide—Cinchocaine—CALM1—Alzheimer's disease	0.000513	0.157	CrCbGaD
Procainamide—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000509	0.00689	CcSEcCtD
Procainamide—CHRM2—telencephalon—Alzheimer's disease	0.000502	0.0122	CbGeAlD
Procainamide—Abdominal discomfort—Donepezil—Alzheimer's disease	0.0005	0.00676	CcSEcCtD
Procainamide—Flushing—Galantamine—Alzheimer's disease	0.0005	0.00676	CcSEcCtD
Procainamide—Cardiac disorder—Galantamine—Alzheimer's disease	0.0005	0.00676	CcSEcCtD
Procainamide—Moclobemide—MAOB—Alzheimer's disease	0.000495	0.152	CrCbGaD
Procainamide—DNMT1—nervous system—Alzheimer's disease	0.000493	0.012	CbGeAlD
Procainamide—SLC22A1—telencephalon—Alzheimer's disease	0.000493	0.012	CbGeAlD
Procainamide—SCN7A—brain—Alzheimer's disease	0.000491	0.0119	CbGeAlD
Procainamide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000489	0.00662	CcSEcCtD
Procainamide—Sunitinib—PTK2B—Alzheimer's disease	0.000485	0.148	CrCbGaD
Procainamide—Sunitinib—LRRK2—Alzheimer's disease	0.000485	0.148	CrCbGaD
Procainamide—DNMT1—central nervous system—Alzheimer's disease	0.000475	0.0115	CbGeAlD
Procainamide—DNMT1—cerebellum—Alzheimer's disease	0.000464	0.0113	CbGeAlD
Procainamide—Depression—Donepezil—Alzheimer's disease	0.000463	0.00627	CcSEcCtD
Procainamide—Dysgeusia—Galantamine—Alzheimer's disease	0.000459	0.0062	CcSEcCtD
Procainamide—Renal failure—Donepezil—Alzheimer's disease	0.000457	0.00618	CcSEcCtD
Procainamide—SCN4A—nervous system—Alzheimer's disease	0.000449	0.0109	CbGeAlD
Procainamide—Neutropenia—Memantine—Alzheimer's disease	0.000443	0.00598	CcSEcCtD
Procainamide—SCN8A—brain—Alzheimer's disease	0.000437	0.0106	CbGeAlD
Procainamide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000435	0.00588	CcSEcCtD
Procainamide—SCN1A—nervous system—Alzheimer's disease	0.000433	0.0105	CbGeAlD
Procainamide—SCN4A—central nervous system—Alzheimer's disease	0.000432	0.0105	CbGeAlD
Procainamide—Bradycardia—Donepezil—Alzheimer's disease	0.000425	0.00574	CcSEcCtD
Procainamide—Malaise—Galantamine—Alzheimer's disease	0.000423	0.00571	CcSEcCtD
Procainamide—Depression—Memantine—Alzheimer's disease	0.000421	0.00569	CcSEcCtD
Procainamide—SCN1A—central nervous system—Alzheimer's disease	0.000416	0.0101	CbGeAlD
Procainamide—Hallucination—Donepezil—Alzheimer's disease	0.000415	0.00561	CcSEcCtD
Procainamide—Renal failure—Memantine—Alzheimer's disease	0.000415	0.00561	CcSEcCtD
Procainamide—Depression—Rivastigmine—Alzheimer's disease	0.000412	0.00557	CcSEcCtD
Procainamide—SCN1A—cerebellum—Alzheimer's disease	0.000407	0.00987	CbGeAlD
Procainamide—Convulsion—Galantamine—Alzheimer's disease	0.000406	0.00549	CcSEcCtD
Procainamide—Renal failure—Rivastigmine—Alzheimer's disease	0.000406	0.00549	CcSEcCtD
Procainamide—Arthralgia—Galantamine—Alzheimer's disease	0.000399	0.00539	CcSEcCtD
Procainamide—Myalgia—Galantamine—Alzheimer's disease	0.000399	0.00539	CcSEcCtD
Procainamide—SCN2A—nervous system—Alzheimer's disease	0.000397	0.00963	CbGeAlD
Procainamide—Discomfort—Galantamine—Alzheimer's disease	0.000394	0.00533	CcSEcCtD
Procainamide—Agranulocytosis—Memantine—Alzheimer's disease	0.000394	0.00532	CcSEcCtD
Procainamide—Confusional state—Galantamine—Alzheimer's disease	0.000386	0.00521	CcSEcCtD
Procainamide—Bradycardia—Memantine—Alzheimer's disease	0.000386	0.00521	CcSEcCtD
Procainamide—SCN9A—brain—Alzheimer's disease	0.000384	0.00932	CbGeAlD
Procainamide—SCN10A—nervous system—Alzheimer's disease	0.000383	0.00928	CbGeAlD
Procainamide—SCN2A—central nervous system—Alzheimer's disease	0.000382	0.00927	CbGeAlD
Procainamide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000377	0.0051	CcSEcCtD
Procainamide—ACHE—cerebellum—Alzheimer's disease	0.000377	0.00914	CbGeAlD
Procainamide—DNMT1—brain—Alzheimer's disease	0.000377	0.00914	CbGeAlD
Procainamide—Hallucination—Memantine—Alzheimer's disease	0.000377	0.0051	CcSEcCtD
Procainamide—Shock—Galantamine—Alzheimer's disease	0.000376	0.00509	CcSEcCtD
Procainamide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000374	0.00506	CcSEcCtD
Procainamide—Chills—Donepezil—Alzheimer's disease	0.000374	0.00506	CcSEcCtD
Procainamide—SCN2A—cerebellum—Alzheimer's disease	0.000374	0.00906	CbGeAlD
Procainamide—Hallucination—Rivastigmine—Alzheimer's disease	0.000369	0.00499	CcSEcCtD
Procainamide—SCN10A—central nervous system—Alzheimer's disease	0.000369	0.00894	CbGeAlD
Procainamide—Anorexia—Galantamine—Alzheimer's disease	0.000365	0.00493	CcSEcCtD
Procainamide—BCHE—forebrain—Alzheimer's disease	0.000363	0.0088	CbGeAlD
Procainamide—Hypotension—Galantamine—Alzheimer's disease	0.000357	0.00483	CcSEcCtD
Procainamide—Dysgeusia—Donepezil—Alzheimer's disease	0.000356	0.00481	CcSEcCtD
Procainamide—Cardiac disorder—Memantine—Alzheimer's disease	0.000352	0.00475	CcSEcCtD
Procainamide—Flushing—Memantine—Alzheimer's disease	0.000352	0.00475	CcSEcCtD
Procainamide—SCN3A—nervous system—Alzheimer's disease	0.000349	0.00846	CbGeAlD
Procainamide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000348	0.00471	CcSEcCtD
Procainamide—SCN5A—nervous system—Alzheimer's disease	0.000348	0.00844	CbGeAlD
Procainamide—Flushing—Rivastigmine—Alzheimer's disease	0.000344	0.00465	CcSEcCtD
Procainamide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000344	0.00465	CcSEcCtD
Procainamide—SCN4A—brain—Alzheimer's disease	0.000343	0.00832	CbGeAlD
Procainamide—Chills—Memantine—Alzheimer's disease	0.00034	0.0046	CcSEcCtD
Procainamide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000337	0.00456	CcSEcCtD
Procainamide—SCN3A—central nervous system—Alzheimer's disease	0.000336	0.00815	CbGeAlD
Procainamide—SCN5A—central nervous system—Alzheimer's disease	0.000335	0.00812	CbGeAlD
Procainamide—BCHE—telencephalon—Alzheimer's disease	0.000334	0.00809	CbGeAlD
Procainamide—Chills—Rivastigmine—Alzheimer's disease	0.000333	0.0045	CcSEcCtD
Procainamide—Decreased appetite—Galantamine—Alzheimer's disease	0.000332	0.0045	CcSEcCtD
Procainamide—SCN1A—brain—Alzheimer's disease	0.000331	0.00802	CbGeAlD
Procainamide—SCN3A—cerebellum—Alzheimer's disease	0.000328	0.00796	CbGeAlD
Procainamide—Malaise—Donepezil—Alzheimer's disease	0.000328	0.00443	CcSEcCtD
Procainamide—Dysgeusia—Memantine—Alzheimer's disease	0.000323	0.00437	CcSEcCtD
Procainamide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000316	0.00427	CcSEcCtD
Procainamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000315	0.00426	CcSEcCtD
Procainamide—Convulsion—Donepezil—Alzheimer's disease	0.000315	0.00425	CcSEcCtD
Procainamide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000313	0.00423	CcSEcCtD
Procainamide—Myalgia—Donepezil—Alzheimer's disease	0.000309	0.00418	CcSEcCtD
Procainamide—Arthralgia—Donepezil—Alzheimer's disease	0.000309	0.00418	CcSEcCtD
Procainamide—ACHE—brain—Alzheimer's disease	0.000306	0.00743	CbGeAlD
Procainamide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000306	0.00414	CcSEcCtD
Procainamide—Discomfort—Donepezil—Alzheimer's disease	0.000306	0.00413	CcSEcCtD
Procainamide—SCN2A—brain—Alzheimer's disease	0.000303	0.00736	CbGeAlD
Procainamide—Body temperature increased—Galantamine—Alzheimer's disease	0.000302	0.00409	CcSEcCtD
Procainamide—Abdominal pain—Galantamine—Alzheimer's disease	0.000302	0.00409	CcSEcCtD
Procainamide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000299	0.00405	CcSEcCtD
Procainamide—Confusional state—Donepezil—Alzheimer's disease	0.000299	0.00404	CcSEcCtD
Procainamide—Malaise—Memantine—Alzheimer's disease	0.000297	0.00402	CcSEcCtD
Procainamide—CHRM2—nervous system—Alzheimer's disease	0.000296	0.00718	CbGeAlD
Procainamide—SCN10A—brain—Alzheimer's disease	0.000293	0.0071	CbGeAlD
Procainamide—Shock—Donepezil—Alzheimer's disease	0.000292	0.00394	CcSEcCtD
Procainamide—SLC22A1—nervous system—Alzheimer's disease	0.000291	0.00706	CbGeAlD
Procainamide—Malaise—Rivastigmine—Alzheimer's disease	0.000291	0.00393	CcSEcCtD
Procainamide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00029	0.00392	CcSEcCtD
Procainamide—SLC22A4—cerebellum—Alzheimer's disease	0.000288	0.00697	CbGeAlD
Procainamide—Convulsion—Memantine—Alzheimer's disease	0.000286	0.00386	CcSEcCtD
Procainamide—CHRM2—central nervous system—Alzheimer's disease	0.000285	0.00692	CbGeAlD
Procainamide—Anorexia—Donepezil—Alzheimer's disease	0.000283	0.00382	CcSEcCtD
Procainamide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000282	0.00381	CcSEcCtD
Procainamide—Arthralgia—Memantine—Alzheimer's disease	0.000281	0.0038	CcSEcCtD
Procainamide—Myalgia—Memantine—Alzheimer's disease	0.000281	0.0038	CcSEcCtD
Procainamide—SLC22A1—central nervous system—Alzheimer's disease	0.00028	0.00679	CbGeAlD
Procainamide—Convulsion—Rivastigmine—Alzheimer's disease	0.00028	0.00378	CcSEcCtD
Procainamide—SLC22A3—nervous system—Alzheimer's disease	0.000278	0.00674	CbGeAlD
Procainamide—Discomfort—Memantine—Alzheimer's disease	0.000277	0.00375	CcSEcCtD
Procainamide—Hypotension—Donepezil—Alzheimer's disease	0.000277	0.00374	CcSEcCtD
Procainamide—Myalgia—Rivastigmine—Alzheimer's disease	0.000275	0.00371	CcSEcCtD
Procainamide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000275	0.00371	CcSEcCtD
Procainamide—Asthenia—Galantamine—Alzheimer's disease	0.000274	0.00371	CcSEcCtD
Procainamide—Confusional state—Memantine—Alzheimer's disease	0.000271	0.00367	CcSEcCtD
Procainamide—Discomfort—Rivastigmine—Alzheimer's disease	0.000271	0.00367	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00027	0.00365	CcSEcCtD
Procainamide—SLC22A3—central nervous system—Alzheimer's disease	0.000268	0.00649	CbGeAlD
Procainamide—SCN3A—brain—Alzheimer's disease	0.000267	0.00647	CbGeAlD
Procainamide—SCN5A—brain—Alzheimer's disease	0.000266	0.00645	CbGeAlD
Procainamide—Confusional state—Rivastigmine—Alzheimer's disease	0.000265	0.00359	CcSEcCtD
Procainamide—Shock—Memantine—Alzheimer's disease	0.000265	0.00358	CcSEcCtD
Procainamide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000264	0.00356	CcSEcCtD
Procainamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000262	0.00354	CcSEcCtD
Procainamide—Shock—Rivastigmine—Alzheimer's disease	0.000259	0.0035	CcSEcCtD
Procainamide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000258	0.00349	CcSEcCtD
Procainamide—Decreased appetite—Donepezil—Alzheimer's disease	0.000258	0.00348	CcSEcCtD
Procainamide—Anorexia—Memantine—Alzheimer's disease	0.000257	0.00347	CcSEcCtD
Procainamide—Oxybuprocaine—BCHE—Alzheimer's disease	0.000256	0.0783	CrCbGaD
Procainamide—Dizziness—Galantamine—Alzheimer's disease	0.000253	0.00342	CcSEcCtD
Procainamide—Hypotension—Memantine—Alzheimer's disease	0.000251	0.0034	CcSEcCtD
Procainamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000251	0.00339	CcSEcCtD
Procainamide—Hypotension—Rivastigmine—Alzheimer's disease	0.000246	0.00333	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000245	0.00332	CcSEcCtD
Procainamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000244	0.0033	CcSEcCtD
Procainamide—Vomiting—Galantamine—Alzheimer's disease	0.000243	0.00329	CcSEcCtD
Procainamide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000242	0.00328	CcSEcCtD
Procainamide—CYP2D6—forebrain—Alzheimer's disease	0.00024	0.00583	CbGeAlD
Procainamide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00024	0.00324	CcSEcCtD
Procainamide—Chloroprocaine—BCHE—Alzheimer's disease	0.000238	0.0728	CrCbGaD
Procainamide—Urticaria—Donepezil—Alzheimer's disease	0.000235	0.00318	CcSEcCtD
Procainamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000234	0.00317	CcSEcCtD
Procainamide—Abdominal pain—Donepezil—Alzheimer's disease	0.000234	0.00317	CcSEcCtD
Procainamide—Decreased appetite—Memantine—Alzheimer's disease	0.000234	0.00316	CcSEcCtD
Procainamide—SLC22A4—brain—Alzheimer's disease	0.000234	0.00566	CbGeAlD
Procainamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000229	0.00309	CcSEcCtD
Procainamide—Nausea—Galantamine—Alzheimer's disease	0.000227	0.00307	CcSEcCtD
Procainamide—Cinchocaine—BCHE—Alzheimer's disease	0.000227	0.0695	CrCbGaD
Procainamide—Procaine—BCHE—Alzheimer's disease	0.000227	0.0695	CrCbGaD
Procainamide—CHRM2—brain—Alzheimer's disease	0.000226	0.00549	CbGeAlD
Procainamide—SLC22A1—brain—Alzheimer's disease	0.000222	0.00539	CbGeAlD
Procainamide—Feeling abnormal—Memantine—Alzheimer's disease	0.000222	0.003	CcSEcCtD
Procainamide—CYP2D6—telencephalon—Alzheimer's disease	0.000221	0.00536	CbGeAlD
Procainamide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00022	0.00298	CcSEcCtD
Procainamide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000218	0.00295	CcSEcCtD
Procainamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000217	0.00293	CcSEcCtD
Procainamide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000215	0.00291	CcSEcCtD
Procainamide—Urticaria—Memantine—Alzheimer's disease	0.000214	0.00289	CcSEcCtD
Procainamide—Body temperature increased—Memantine—Alzheimer's disease	0.000213	0.00288	CcSEcCtD
Procainamide—Abdominal pain—Memantine—Alzheimer's disease	0.000213	0.00288	CcSEcCtD
Procainamide—Asthenia—Donepezil—Alzheimer's disease	0.000213	0.00288	CcSEcCtD
Procainamide—SLC22A3—brain—Alzheimer's disease	0.000213	0.00515	CbGeAlD
Procainamide—Pruritus—Donepezil—Alzheimer's disease	0.00021	0.00284	CcSEcCtD
Procainamide—Urticaria—Rivastigmine—Alzheimer's disease	0.000209	0.00283	CcSEcCtD
Procainamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000208	0.00281	CcSEcCtD
Procainamide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000208	0.00281	CcSEcCtD
Procainamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000203	0.00274	CcSEcCtD
Procainamide—Hypersensitivity—Memantine—Alzheimer's disease	0.000198	0.00268	CcSEcCtD
Procainamide—BCHE—nervous system—Alzheimer's disease	0.000197	0.00478	CbGeAlD
Procainamide—Dizziness—Donepezil—Alzheimer's disease	0.000196	0.00265	CcSEcCtD
Procainamide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000194	0.00262	CcSEcCtD
Procainamide—Asthenia—Memantine—Alzheimer's disease	0.000193	0.00261	CcSEcCtD
Procainamide—Pruritus—Memantine—Alzheimer's disease	0.00019	0.00257	CcSEcCtD
Procainamide—SLC22A5—cerebellum—Alzheimer's disease	0.00019	0.00461	CbGeAlD
Procainamide—BCHE—central nervous system—Alzheimer's disease	0.00019	0.0046	CbGeAlD
Procainamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000189	0.00255	CcSEcCtD
Procainamide—Vomiting—Donepezil—Alzheimer's disease	0.000188	0.00255	CcSEcCtD
Procainamide—Pruritus—Rivastigmine—Alzheimer's disease	0.000186	0.00252	CcSEcCtD
Procainamide—BCHE—cerebellum—Alzheimer's disease	0.000185	0.00449	CbGeAlD
Procainamide—Diarrhoea—Memantine—Alzheimer's disease	0.000184	0.00249	CcSEcCtD
Procainamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00018	0.00244	CcSEcCtD
Procainamide—Dizziness—Memantine—Alzheimer's disease	0.000178	0.00241	CcSEcCtD
Procainamide—Nausea—Donepezil—Alzheimer's disease	0.000176	0.00238	CcSEcCtD
Procainamide—Dizziness—Rivastigmine—Alzheimer's disease	0.000174	0.00235	CcSEcCtD
Procainamide—Vomiting—Memantine—Alzheimer's disease	0.000171	0.00231	CcSEcCtD
Procainamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000167	0.00226	CcSEcCtD
Procainamide—Nausea—Memantine—Alzheimer's disease	0.00016	0.00216	CcSEcCtD
Procainamide—Moclobemide—CYP2D6—Alzheimer's disease	0.000157	0.0482	CrCbGaD
Procainamide—Nausea—Rivastigmine—Alzheimer's disease	0.000156	0.00211	CcSEcCtD
Procainamide—SLC22A5—brain—Alzheimer's disease	0.000155	0.00375	CbGeAlD
Procainamide—BCHE—brain—Alzheimer's disease	0.000151	0.00365	CbGeAlD
Procainamide—CYP2D6—nervous system—Alzheimer's disease	0.00013	0.00316	CbGeAlD
Procainamide—CYP2D6—central nervous system—Alzheimer's disease	0.000126	0.00305	CbGeAlD
Procainamide—CYP2D6—cerebellum—Alzheimer's disease	0.000123	0.00298	CbGeAlD
Procainamide—Metoclopramide—CYP2D6—Alzheimer's disease	0.000101	0.0311	CrCbGaD
Procainamide—CYP2D6—brain—Alzheimer's disease	9.97e-05	0.00242	CbGeAlD
Procainamide—Lidocaine—CYP2D6—Alzheimer's disease	8.06e-05	0.0247	CrCbGaD
Procainamide—SCN9A—Developmental Biology—IL6—Alzheimer's disease	9.09e-06	0.00014	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CHAT—Alzheimer's disease	8.98e-06	0.000138	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPI1—Alzheimer's disease	8.98e-06	0.000138	CbGpPWpGaD
Procainamide—BCHE—Metabolism—A2M—Alzheimer's disease	8.96e-06	0.000138	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.96e-06	0.000138	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	8.9e-06	0.000137	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	8.89e-06	0.000136	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCA1—Alzheimer's disease	8.85e-06	0.000136	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—Alzheimer's disease	8.7e-06	0.000133	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	8.67e-06	0.000133	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INPP5D—Alzheimer's disease	8.64e-06	0.000133	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	8.61e-06	0.000132	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MAOB—Alzheimer's disease	8.61e-06	0.000132	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	8.56e-06	0.000131	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	8.48e-06	0.00013	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	8.44e-06	0.00013	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—Alzheimer's disease	8.39e-06	0.000129	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—F2—Alzheimer's disease	8.38e-06	0.000129	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPI1—Alzheimer's disease	8.37e-06	0.000128	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CHAT—Alzheimer's disease	8.37e-06	0.000128	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—Alzheimer's disease	8.35e-06	0.000128	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—Alzheimer's disease	8.35e-06	0.000128	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	8.31e-06	0.000128	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	8.29e-06	0.000127	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	8.28e-06	0.000127	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	8.28e-06	0.000127	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS1—Alzheimer's disease	8.19e-06	0.000126	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO1—Alzheimer's disease	8.19e-06	0.000126	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	8.19e-06	0.000126	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	8.1e-06	0.000124	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	8.1e-06	0.000124	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	8.06e-06	0.000124	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—Alzheimer's disease	8.06e-06	0.000124	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—Alzheimer's disease	8.06e-06	0.000124	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	8.05e-06	0.000124	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2D6—Alzheimer's disease	8.03e-06	0.000123	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MAOB—Alzheimer's disease	8.03e-06	0.000123	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—Alzheimer's disease	8.02e-06	0.000123	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—A2M—Alzheimer's disease	8.01e-06	0.000123	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.99e-06	0.000123	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—Alzheimer's disease	7.94e-06	0.000122	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	7.93e-06	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	7.88e-06	0.000121	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	7.84e-06	0.00012	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ACHE—Alzheimer's disease	7.8e-06	0.00012	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	7.8e-06	0.00012	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GAPDH—Alzheimer's disease	7.73e-06	0.000119	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	7.72e-06	0.000118	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INPP5D—Alzheimer's disease	7.71e-06	0.000118	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—Alzheimer's disease	7.71e-06	0.000118	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—Alzheimer's disease	7.71e-06	0.000118	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARGC1A—Alzheimer's disease	7.63e-06	0.000117	CbGpPWpGaD
Procainamide—ACHE—Metabolism—BCHE—Alzheimer's disease	7.62e-06	0.000117	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	7.61e-06	0.000117	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INS—Alzheimer's disease	7.59e-06	0.000117	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HMOX1—Alzheimer's disease	7.59e-06	0.000117	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	7.52e-06	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	7.51e-06	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	7.51e-06	0.000115	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—F2—Alzheimer's disease	7.48e-06	0.000115	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	7.47e-06	0.000115	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—A2M—Alzheimer's disease	7.46e-06	0.000115	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—Alzheimer's disease	7.43e-06	0.000114	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—Alzheimer's disease	7.43e-06	0.000114	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	7.43e-06	0.000114	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.35e-06	0.000113	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	7.35e-06	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	7.32e-06	0.000112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO1—Alzheimer's disease	7.31e-06	0.000112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS1—Alzheimer's disease	7.31e-06	0.000112	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	7.22e-06	0.000111	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PLCB1—Alzheimer's disease	7.19e-06	0.00011	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ND1—Alzheimer's disease	7.18e-06	0.00011	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2D6—Alzheimer's disease	7.17e-06	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	7.08e-06	0.000109	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.05e-06	0.000108	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—Alzheimer's disease	7.02e-06	0.000108	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	6.98e-06	0.000107	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCA1—Alzheimer's disease	6.97e-06	0.000107	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ACHE—Alzheimer's disease	6.97e-06	0.000107	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—LPL—Alzheimer's disease	6.94e-06	0.000107	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	6.91e-06	0.000106	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	6.88e-06	0.000106	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	6.8e-06	0.000104	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—Alzheimer's disease	6.77e-06	0.000104	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	6.67e-06	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	6.63e-06	0.000102	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	6.55e-06	0.000101	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO1—Alzheimer's disease	6.53e-06	0.0001	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	6.53e-06	0.0001	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ACHE—Alzheimer's disease	6.49e-06	9.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	6.48e-06	9.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	6.48e-06	9.94e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	6.42e-06	9.85e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PLCB1—Alzheimer's disease	6.41e-06	9.84e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	6.4e-06	9.82e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.29e-06	9.65e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—Alzheimer's disease	6.25e-06	9.59e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCA1—Alzheimer's disease	6.21e-06	9.54e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO1—Alzheimer's disease	6.08e-06	9.34e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	6.08e-06	9.34e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—BCHE—Alzheimer's disease	6.07e-06	9.31e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	6e-06	9.21e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—Alzheimer's disease	5.98e-06	9.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	5.97e-06	9.16e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CALM1—Alzheimer's disease	5.84e-06	8.96e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOE—Alzheimer's disease	5.82e-06	8.93e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAV1—Alzheimer's disease	5.77e-06	8.85e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	5.73e-06	8.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	5.71e-06	8.76e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—Alzheimer's disease	5.66e-06	8.69e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—BCHE—Alzheimer's disease	5.66e-06	8.68e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.63e-06	8.64e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	5.55e-06	8.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	5.53e-06	8.48e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LPL—Alzheimer's disease	5.47e-06	8.39e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	5.36e-06	8.22e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	5.34e-06	8.19e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	5.33e-06	8.18e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—Alzheimer's disease	5.33e-06	8.18e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	5.22e-06	8.02e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.22e-06	8.01e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	5.17e-06	7.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	5.11e-06	7.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	5.09e-06	7.81e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—Alzheimer's disease	5.07e-06	7.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	5.06e-06	7.76e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—Alzheimer's disease	4.97e-06	7.63e-05	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—Alzheimer's disease	4.93e-06	7.57e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—Alzheimer's disease	4.92e-06	7.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	4.91e-06	7.53e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—Alzheimer's disease	4.88e-06	7.48e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	4.84e-06	7.43e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	4.78e-06	7.34e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	4.76e-06	7.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	4.74e-06	7.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	4.65e-06	7.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	4.63e-06	7.11e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	4.62e-06	7.1e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	4.62e-06	7.1e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CALM1—Alzheimer's disease	4.6e-06	7.06e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—Alzheimer's disease	4.58e-06	7.03e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	4.57e-06	7.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	4.56e-06	7e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAV1—Alzheimer's disease	4.54e-06	6.97e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	4.46e-06	6.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	4.44e-06	6.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SST—Alzheimer's disease	4.44e-06	6.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	4.44e-06	6.81e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	4.44e-06	6.81e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	4.43e-06	6.8e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	4.42e-06	6.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	4.4e-06	6.75e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—Alzheimer's disease	4.39e-06	6.74e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—Alzheimer's disease	4.36e-06	6.69e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—Alzheimer's disease	4.35e-06	6.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APP—Alzheimer's disease	4.33e-06	6.64e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	4.27e-06	6.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	4.15e-06	6.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—A2M—Alzheimer's disease	4.12e-06	6.33e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CALM1—Alzheimer's disease	4.1e-06	6.29e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—Alzheimer's disease	4.09e-06	6.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	4.08e-06	6.26e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—Alzheimer's disease	4.06e-06	6.23e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAV1—Alzheimer's disease	4.05e-06	6.21e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—Alzheimer's disease	3.99e-06	6.12e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—Alzheimer's disease	3.99e-06	6.12e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	3.92e-06	6.02e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—Alzheimer's disease	3.91e-06	6.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	3.81e-06	5.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	3.78e-06	5.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	3.72e-06	5.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	3.7e-06	5.68e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CALM1—Alzheimer's disease	3.66e-06	5.62e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	3.65e-06	5.61e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—Alzheimer's disease	3.65e-06	5.6e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAV1—Alzheimer's disease	3.62e-06	5.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	3.59e-06	5.5e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—Alzheimer's disease	3.56e-06	5.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	3.54e-06	5.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	3.52e-06	5.4e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—Alzheimer's disease	3.49e-06	5.36e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—Alzheimer's disease	3.43e-06	5.27e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CALM1—Alzheimer's disease	3.41e-06	5.24e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—Alzheimer's disease	3.4e-06	5.22e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAV1—Alzheimer's disease	3.37e-06	5.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.36e-06	5.16e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.36e-06	5.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	3.35e-06	5.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	3.24e-06	4.97e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—Alzheimer's disease	3.18e-06	4.88e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—Alzheimer's disease	3.14e-06	4.82e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.12e-06	4.79e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—Alzheimer's disease	3.12e-06	4.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	3.1e-06	4.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	3.08e-06	4.72e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—Alzheimer's disease	3.06e-06	4.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	3.02e-06	4.63e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—Alzheimer's disease	2.96e-06	4.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.95e-06	4.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	2.94e-06	4.51e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—Alzheimer's disease	2.91e-06	4.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	2.86e-06	4.39e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.86e-06	4.38e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—Alzheimer's disease	2.8e-06	4.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	2.8e-06	4.3e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—Alzheimer's disease	2.73e-06	4.2e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	2.61e-06	4.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	2.6e-06	3.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	2.6e-06	3.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	2.58e-06	3.96e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—Alzheimer's disease	2.55e-06	3.91e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	2.5e-06	3.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	2.48e-06	3.81e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.46e-06	3.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—Alzheimer's disease	2.45e-06	3.77e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.45e-06	3.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.4e-06	3.69e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	2.33e-06	3.58e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.25e-06	3.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.24e-06	3.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.24e-06	3.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.22e-06	3.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.19e-06	3.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.15e-06	3.3e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.02e-06	3.1e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—Alzheimer's disease	2e-06	3.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.95e-06	2.99e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.89e-06	2.89e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.88e-06	2.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.86e-06	2.86e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.67e-06	2.56e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.66e-06	2.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.64e-06	2.52e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.64e-06	2.51e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—Alzheimer's disease	1.61e-06	2.46e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—Alzheimer's disease	1.58e-06	2.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.52e-06	2.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.52e-06	2.33e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.41e-06	2.16e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—Alzheimer's disease	1.41e-06	2.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.4e-06	2.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.29e-06	1.98e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.29e-06	1.98e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.26e-06	1.93e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.17e-06	1.8e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.06e-06	1.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	9.71e-07	1.49e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	8.96e-07	1.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.47e-07	9.93e-06	CbGpPWpGaD
